Free Trial

Annexon (ANNX) SEC Filings & 10K Form

Annexon logo
$6.12 -0.21 (-3.32%)
(As of 11/15/2024 ET)

Recent Annexon SEC Filings

DateFilerForm TypeView
11/14/2024
6:21 PM
Annexon (Subject)
BB BIOTECH AG (Filed by)
Form SC 13G/A
11/14/2024
5:46 PM
Annexon (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
11/12/2024
8:38 AM
Adage Capital Management, L.P. (Filed by)
Annexon (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
Annexon (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
11/01/2024
3:15 PM
Annexon (Issuer)
Love Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
5:06 PM
Annexon (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/21/2024
7:15 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:09 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
1:03 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2024
7:01 AM
Annexon (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/20/2024
3:30 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
11:32 AM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
3:30 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
9:24 AM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
3:30 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
9:15 AM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
3:34 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:00 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
1:08 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
11:15 PM
Annexon (Filer)
Form EFFECT
08/12/2024
3:59 PM
Annexon (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/12/2024
7:05 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
6:53 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
7:11 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:46 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:48 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:49 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
2:38 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
2:24 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
2:25 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
4:43 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:14 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
11:28 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
8:41 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:42 PM
Annexon (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:43 PM
Annexon (Issuer)
Choi Jung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:44 PM
Annexon (Issuer)
Satter Muneer A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:45 PM
Annexon (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:40 PM
Annexon (Issuer)
Cockroft Bettina M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:42 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
8:57 PM
Annexon (Filer)
Form 424B5
There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t
06/05/2024
3:23 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
4:21 PM
Annexon (Filer)
Form 424B5
06/04/2024
6:05 AM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
7:35 PM
Annexon (Subject)
BB BIOTECH AG (Filed by)
Form SC 13G
04/10/2024
6:17 PM
Annexon (Issuer)
Carson William H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
11:15 PM
Annexon (Filer)
Form EFFECT
03/26/2024
4:01 PM
Annexon (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2024
4:05 PM
Annexon (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/26/2024
3:05 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:10 PM
Annexon (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
2:12 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:12 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
2:15 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
7:46 PM
Annexon (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
02/14/2024
6:56 PM
Annexon (Issuer)
Love Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:59 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:52 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:54 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:45 PM
Annexon (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13G/A
02/14/2024
11:43 AM
Annexon (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/14/2024
9:26 AM
Annexon (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Form SC 13G/A
02/13/2024
6:23 PM
Annexon (Subject)
Logos Global Management LP (Filed by)
Form SC 13G/A
02/13/2024
5:57 PM
Annexon (Subject)
Bain Capital Life Sciences Fund, L.P. (Filed by)
Form SC 13G/A
02/12/2024
2:39 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:40 PM
Annexon (Subject)
Lew Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:41 PM
Annexon (Subject)
Love Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
2:45 PM
Annexon (Subject)
Overdorf Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
6:02 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Annexon (Subject)
Form SC 13G/A
01/23/2024
3:57 PM
Annexon (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:58 PM
Annexon (Issuer)
Overdorf Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:53 AM
Annexon (Subject)
FMR LLC (Filed by)
Form SC 13G
12/29/2023
3:12 PM
Annexon (Issuer)
Yednock Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:30 PM
Annexon (Issuer)
Annexon (Issuer)
Satter Muneer A (Reporting)
Satter Muneer A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
3:50 PM
Annexon (Subject)
Yednock Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
4:28 PM
Annexon (Filer)
Form 8-K/A
12/20/2023
4:17 PM
Annexon (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
4:24 PM
Annexon (Subject)
Form FWP
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ANNX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners